Daewoong Pharma and GS Retail Lift Q3 Operating Profit
Drugmaker Daewoong Pharma and retailer GS Retail both reported higher third-quarter operating profit compared with a year earlier.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
Reuters reports that Daewoong Pharma posted third-quarter operating profit of 77 billion won, up 43.5% from a year earlier.
Retailer GS Retail booked 132 billion won in operating profit over the same period, a 19% increase on the year before.
why it matters
Results of this size mainly affect the shares of these two companies and investor interest in the South Korean market. The faster growth at the drugmaker points to differing momentum across sectors in the Korean economy.
tags
instruments
sources
- Daewoong Pharma Q3 Operating Profit 77 Billion Won, Up 43.5% From Year Earlier — Reuters, 4 November 2026 at 01:07 UTC
- Gs Retail Q3 Operating Profit 132 Billion Won, Up 19% From Year Earlier — Reuters, 4 November 2026 at 01:05 UTC
- Tym Corp Q3 Operating Profit 35.8 Billion Won, Up 124.7% From Year Earlier — Reuters, 4 November 2026 at 01:14 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗